Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hematology 2017

Scientific Session

11th International Conference on Hematology and Hematological Oncology

Date: November 08-09, 2017

Venue: Las Vegas, USA

Hematology 2017 has been designed with many interesting and informative scientific sessions; it includes all possible aspects of Hematology research.

Track 1: Hematology

Erythrocytes are also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of hemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the W.B.C (leucocytes) act as the defending cells in protecting the immune system from the foreign cells. These leucocytes are multipotent cells in bone marrow and there life span is of 3-4 days where the yellow blood cells are called as thrombocytes they are where small and irregular in shape they have life span of 5-9 days they are mostly seen in mammals they help in clotting of blood which are in fibrin form called as thrombosis these lead to heart stroke, blockage of blood in blood mostly in arms and legs. where C.B.C is known as complete blood count is done to know the number of cells in a body these are mainly done by lab technician presently they are been tested by automatic analyzer the high and low amount of cells will lead to many diseases. Decrease of R.B.C  in the body these causes of anemia which leads to weakness, feeling of tired, shortness of breath and person will be noticeably pale. Formation of blood cellular components are called as Hematopoiesis and all the cellular blood components are derived from hematopoiesis stem cells in a healthy individual nearly 1011–1012  new blood cells are produced these help in steady peripheral circulation. If there is a increases of R.B.C in the body these causes polycythemia these can be measured through hematocrit level.

Track 2: Blood Disorders

Hemophilia A is a genetic deficiency in clotting factor VIII, which causes increased bleeding and usually affects males. About 70% of the time it is inherited as an X-linked recessive trait, but around 30% of cases arise from spontaneous mutations. Hemophilia B  is a blood clotting disorder caused by a mutation of the factor IX gene, leading to a deficiency of factor IX. It is the second-most common form of haemophilia, rarer than haemophilia A. It is sometimes called Christmas disease, named after Stephen Christmas, the first patient described with this disease.In addition, the first report of its identification was published in the Christmas edition of the British Medical JournalHemophilia C  is a mild form of haemophilia affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B. In the USA it is thought to affect 1 in 100,000 of the adult population, making it 10% as common as haemophilia A. Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenia, primary immune thrombocytopenia,primary immune thrombocytopenic purpura or autoimmune thrombocytopenic purpura, is defined as isolated low platelet count (thrombocytopenia) with normal bone marrow and the absence of other causes of thrombocytopenia Von Willebrand diseases is the most common hereditary coagulation abnormality described in humans. Platelets also called "thrombocytes" are blood cells whose function (along with the coagulation factors) is to stop bleeding by clumping and clogging blood vessel injuries. Platelets have no cell nucleus: Coagulation is highly conserved throughout biology; in all mammals, coagulation involves both a cellular (platelet) and a protein (coagulation factor) component and these are occoured due to genetic blood disorders

Track 3: Hematologic Malignancies

Lymphatic leukemia which effect the white blood cells(w.b.c) they are closely related to the lymphomas and some of them are unitary diseases which related to the adult T cells leukemia these come under the lymphoproliferative disorders. Mostly they involve in the B-cell sub type lymphocytes. The myeloid leukemia is preferred to the granulocyte precursor in the bone marrow and spinal cord and these arises the abnormal growth in the blood from tissues in the bone marrow. They are mainly related to the hematopoietic cells and these sub title into acute and chronic lymphoblastic leukemia. The acute leukemia is that rapidly producing immature blood cells as they are bulk number of cells healthy cells are not produced in bone marrow due this spill over the blood stream which spread to other body parts. Where as in chronic leukemia highly bulid of  matured cells are formed but still abnormal white cells are formed these can not be treated immediately mostly seen in older people. The cancer which originate from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases is treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell are called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myleoma. The further details on malignance are been discussed in Hematology oncology conference-2015.   

Track 4: Hematology and immunology

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis  lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Track 5: Blood Transplantation

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoitic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large needlethat reaches the center of the bone. Acute myeloid leukemia  is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing. Metabolic syndrome is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions, obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density lipoprotein (HDL) levels. Metabolic syndrome increases the risk developing cardiovascular disease and diabetes.

Track 6: Diagnosis and Treatment

Palliative care is a multidisciplinary approach to specialised medical care for people with serious illnesses The spleen, similar in structure to a large lymph node, acts as a blood filter. Anticoagulants (antithrombics) are a class of drugs that work to prevent the coagulation (clotting) of blood. Some anticoagulants are used in medical equipment, such as test  tubes ,blood transfusion bags, and renal dialysis equipment. An  vena cava filter  is a type of vascular filter, a medical device that is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to presumably prevent life-threatening pulmonary emboli is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. The subspecialty of oncology that focuses on radiotherapy is called radiation oncology. Translational research is another term for translated research and translational science, Applying knowledge from basic science is a major stumbling block in science, partially due to the compartmentalization within science. Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.

Track 7: New Drug Development in Haematology

The development of antibiotic resistance in particular stems from the drugs targeting only specific bacterial molecules. Because the drug is so specific, any mutation in these molecules will interfere with or negate its destructive effect, resulting in antibiotic resistance. Known as Drug delivery Conditions treated with combination therapy include tuberculosis, leprosy, cancer, malaria, and HIV/AIDS. One major benefit of combination therapies is that they reduce development of drug resistance, since a pathogen or tumor is less likely to have resistance to multiple drugs simultaneously. Artemisinin-based monotherapies for malaria are explicitly discouraged to avoid the problem of developing resistance to the newer treatment. Drug Induced Blood Disorders causes of sickle cell anemia,pale skin non steroids anti inflammatory drugs which causes ulcers Using drug repositioning, pharmaceutical companies have achieved a number successes, for example Pfizer's Viagra in erectile dysfunction and Celgene's thalidomide in severe erythema nodosum leprosum. Smaller companies, including Ore Pharmaceuticals, Biovista, Numedicus, Melior Discovery and SOM Biotech are also performing drug repositioning on a systematic basis. These companies use a combination of approaches including in silico biology and in vivo/in vitro experimentation to assess a compound and develop and confirm hypotheses concerning its usage for new indications.

Track 8: Hematology Research

Lymphatic diseases this is a type of cancer of the lymphatic system. It can start almost any where in the body. It's believed to be caused by HIV, Epstein-Barr Syndrome, age and family history. Symptoms include weight loss, fever, swollen lymph nodes, night sweats, itchy skin, fatigue, chest pain, coughing and/or trouble swallowing. The lymphatic system is part of the circulatory system, comprising a network of lymphatic vessels that carry a clear fluid called lymph  directionally towards the heart. The lymphatic system was first described in the seventeenth century independently by Olaus Rudbeck and Thomas Bartholin. Unlike the cardiovascular system the lymphatic system is not a closed system. The human circulatory system processes an average of 20 litres of blood per day through capillary filtrationwhich removes plasma while leaving the blood cells. Roughly 17 litres of the filtered plasma get reabsorbed directly into the blood vessels, while the remaining 3 litres are left behind in the interstitial fluid. One of the main functions of the lymph system is to provide an accessory return route to the blood for the surplus 3 litres. Lymphatic diseases are of Non-Hodgkin's Lymphoma, Hodgkins. The thymus is a specialized primary lymphoid organ of the immune system. Within the thymus, T cells or T lymphocytes mature. T cells are critical to the adaptive immune system, where the body adapts specifically to foreign invaders. One of the example of lymph node development. Formation of lymph node into the tumor which lead to cancer called oncology.

Track 9: Various Aspects of Haematology

Pediatric Haematology and Oncology is an international peer-reviewed medical journal that covers all aspects of pediatrichematology and oncology. The journal covers immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians specialized in hematology are known as hematologists or haematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the hematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various hematological test results and blood clotting test results. In some institutions, hematologists also manage the hematology laboratory. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or haematopathologists. Experimental Hematology is a peer-reviewed medical journal of hematology, which publishes original research articles and reviews, as well as the abstracts of the annual proceedings of the Society for Hematology and Stem Cells and they should be done under the Hematology guidlines.

Track 10: Blood Based Products

blood substitute  is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Thus far, there are no well-accepted oxygen-carrying blood substitutes, which is the typical objective of a red blood cell transfusion; however, there are widely available non-blood volume expanders for cases where only volume restoration is required. These are helping doctors and surgeons avoid the risks of disease transmission and immune suppression, address the chronic blood donor shortage, and address the concerns of Jehovah's Witnesses and others who have religious objections to receiving transfused blood. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating withUV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion. This type of approach to increase blood safety is also known as “pathogen inactivation” in the industry. An artificial cell or minimal cell is an engineered particle that mimics one or many functions of a biological cell. The term does not refer to a specific physical entity, but rather to the idea that certain functions or structures of biological cells can be replaced or supplemented with a synthetic entity. Often, artificial cells are biological or polymeric membranes which enclose biologically active materials. As such, nanoparticles, liposomes, polymersomes, microcapsules and a number of other particles have qualified as artificial cells. Manufacturing of semi synthetic products of drugs are known as therapeutic biological products. Anticoagulants (antithrombics) are a class of drugs that work to prevent the coagulation (clotting) of blood. Such substances occur naturally in leeches and blood-sucking insects.

Track 11: Hematologic oncology

Hematologic oncology  is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of etiology. It involves treating diseases that affect the production of blood and its components, such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Haematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by haematology. A few of these different types of blood conditions that are looked at include anemia, hemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed

  • Myeloma
  • Myelodysplastic syndromes
  • Multiple Myeloma
  • Leukaemia
  • Lymphoma

Lymphatic leukemia which effect the white blood cells(w.b.c) they are closely related to the lymphomas and some of them are unitary diseases which related to the adult T cells leukemia these come under the lymphoproliferative disorders. Mostly they involve in the B-cell sub type lymphocytes. The myeloid leukemia is preferred to the granulocyte precursor in the bone marrow and spinal cord and these arises the abnormal growth in the blood from tissues in the bone marrow. They are mainly related to the hematopoietic cells and these sub title into acute and chronic lymphoblastic leukemia. The acute leukemia is that rapidly producing immature blood cells as they are bulk number of cells healthy cells are not produced in bone marrow due this spill over the blood stream which spread to other body parts. Where as in chronic leukemia highly bulid of  matured cells are formed but still abnormal white cells are formed these can not be treated immediately mostly seen in older people. The cancer which originate from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases is treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell are called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myleoma. The further details on malignance are been discussed in Hematology oncology conference-2015

Track 12: Hematologic diseases

Hematologic diseases are disorders which primarily affect the blood

1) Anemias

1.1Nutritional anemias

1.2Non-nutritional (hemolytic, aplastic and other) anemias

1.3Sickle cell Anemias

2) Blood cancers

2.1Lymphoma

2.2Leukemia

2.3Myeloma

2.4Malignant immunoproliferative diseases

3) Coagulation, purpura, and other hemorrhagic conditions

4) Infection-related

4.1Bacterium-related

4.2Protozoan-related

5) Immune system regulation-related

Track 13: Hematology and Nursing

Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. Some of the more commonly-known blood diseases and disorders a hematology nurse may encounter include: leukemia, lymphoma, sickle cell anemia and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research and chemotherapy. Advanced practice hematology nurses have some prescriptive authority and can also order diagnostic lab work done.Hematology nurses are specially trained to provide nursing care for patients with blood diseases or disorders. Some of the more commonly-known blood diseases and disorders a hematology nurse may encounter include: leukemia, lymphoma, sickle cell anemia and hemophilia. Hematology nurses initiate a plan of care to manage symptoms that result from such blood problems. Hematology nursing is often closely associated with oncology nursing, and some nurses will help patients with pain management if their cancer is particularly aggressive. Hematology nurses may work with adults only or specialize in working only with children. Their responsibilities include: taking medical histories, performing examinations, starting IVs and working with physicians to diagnose various blood diseases and disorders. Hematology nurses also educate patients and their families on how to live with and manage their blood disease. They may also assist with blood transfusions, blood tests, research and chemotherapy. Advanced practice hematology nurses have some prescriptive authority and can also order diagnostic lab work done.

Track 14: Hematology and Pharma industry

The global market for Hematologic drugs is predicted to grow twice as fast as that of other pharmaceuticals over the next five years.

Top companies in the list includes janssen biotech,takeda oncology,Bristol-Mayers squibb,boehringer ingelheim, Roche, Novartis, Celgene, Johnson & Johnson, Bristol-Myers Squibb, Lilly, Takeda, AstraZeneca, Merck & Co., Amgen, Pfizer, Astellas, Bayer, Otsuka, Sanofi, Merck KGaA, Eisai, AbbVie, Pharmacyclics, Incyte

  • Biological Drugs
  • Generic Drugs
  • Increasing Investments
  • Healthcare Expenditures
  • Cancer Pharmaceutical Companies

Track 15: Blood Transplantation

The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoitic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large needlethat reaches the center of the bone. Acute myeloid leukemia  is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing. Metabolic syndrome is a disorder of energy utilization and storage, diagnosed by a co-occurrence of three out of five of the following medical conditions, obesity, elevated blood pressure, elevated fasting plasma glucose, high serum triglycerides, and low high-density lipoprotein (HDL) levels. Metabolic syndrome increases the risk developing cardiovascular disease and diabetes.

Track 16: Palliative care

 Palliative care is a multidisciplinary approach to specialised medical care for people with serious illnesses The spleen, similar in structure to a large lymph node, acts as a blood filter. Anticoagulants (antithrombics) are a class of drugs that work to prevent the coagulation (clotting) of blood. Some anticoagulants are used in medical equipment, such as test  tubes ,blood transfusion bags, and renal dialysis equipment. An  vena cava filter  is a type of vascular filter, a medical device that is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to presumably prevent life-threatening pulmonary emboli is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. The subspecialty of oncology that focuses on radiotherapy is called radiation oncology. Translational research is another term for translated research and translational science, Applying knowledge from basic science is a major stumbling block in science, partially due to the compartmentalization within science. Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.

Track 17: Hematology : Case Report

A case report is a detailed report consisting the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. A case report is generally considered a type of evidence of the work carried out and the output attained.

Case studies are extremely useful records of the clinical practices of a profession. They are a record of clinical interactions which help us to frame questions for more rigorously designed clinical studies. Case studies also provide valuable teaching material, demonstrating both classical and unusual presentations which may challenge the practitioner.

Track 18: Entrepreneurs Investment Meet

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

About Conference

Conferenceseries LLC is overwhelmed to announce the commencement of its eleventh consecutive Hematology conference.

11th International Conference on Hematology and Hematological Oncology

Date: November 08-09, 2017

Venue: Las Vegas, Nevada, USA.

Hematology 2017 will be organized around the theme “Fight with Blood Cancer: There is a Lifesaver in You”.

Hematology 2017 is comprised of many interactive scientific sessions on different types of Blood disorders as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under a one roof to explore every single aspect of Hematology and Blood Diseases.  Hematology 2017 welcomes the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it in Hematology conferences.

According to market study, market value of Hematology at present is $15.13 billion. A major part of research is going on at the top Universities across the globe, on Hematology conference and the grants allotted for this research field is around $10.54 billion. Many companies are associated with the blood testing equipment along with various diagnostic instruments, hematologic drugs and other therapeutics, the revenue generated is around $21.1 billion on average by this companies. Besides this various societies and research labs are also associated in this research field.

Hematology conferences are organized  Conference Series LLC  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Hematology 2017 will  provide an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster and Live Streaming, B2B and Scientific Meetings.

Why to attend?

Hematology 2017 will provide a stimulating scientific environment and a platform for the participants to exchange ideas, establish research collaboration and networking by attending the Hematology conferences. It will be amazing opportunity for the attendees to explore the beautiful city with gaining knowledge, sure to raise insights, conflate present with future and cogitate on ideas and reality in Hematology meetings. To fight aginst these hard to cure blood diseases, Hematology 2017  has taken this intiative to  explore every aspects of Hematology research.

Target Audience

  • Hematologists
  • Immunologists
  • Pathologists
  • Oncologists
  • Research Scholars
  • Industrial professionals from biomedical companies and healthcare sectors.
  • Student delegates from Academia and Research along with the industrial professionals

Market Analysis

Summary

Hematology is a branch of biology that includes various research areas such as pathology, internal medicine, clinical laboratory, physiology, immunology and pediatrics. This conference will witness a conglomeration of various arenas in Hematology and as it involves a vast range of medical streams within it, this conference will be an excellent platform for interdisciplinary interactions, to exchange and share knowledge under a single roof.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Hematology 2017, where you will be sure to have a meaningful experience with scholars from around the world.

For more details please visit: http://hematology.conferenceseries.com/

Importance & Scope:

Hematology 2017, Las Vegas, Nevada, USA is expected to offer the best platform for the expertise, researchers, students and business delegates with its well organized scientific program covering every minute detail about hematology and blood diseases, from the basic causes behind blood diseases to the latest trends in diagnostic and treatment of blood diseases. This international event is an effort to find a weapon against chronic disorders like blood cancer, Sickle cell anemia, hemophilia, lymphoma and myeloma and to discuss the role of Immunoglobulin in blood, antibody and antigen reactions, the red blood cell and the immunological properties of blood which gives a better insight about the associated causes and disease portfolio.

Conferenceseries LLC welcomes all the hematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of the esteemed Hematology 2017. Advanced Diagnostic and therapeutic equipment  along with the novel drugs for  the  blood diseases are an integral part of the Hematology research, hence it will be an excellent amalgamation of academia and industry as it involves  every aspects of empirical and conceptual thinking  in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry. 

Why Las Vegas?

The name Las Vegas was given to the area in 1829 by a Mexican scout named Raphael Rivera, a member of the Antonio Armijo trading party that was traveling to Los Angeles, and stopped for water there while heading north and west on the Old Spanish Trail from New Mexico. At that time, several parts of the valley contained artesian wells surrounded by extensive green areas; Las Vegas means the meadows in Spanish. The flows from the wells fed the Las Vegas Wash, which runs to the Colorado River. It’s a town whose story has been told a huge number of times, in books, for example, “Fear and Loathing in Las Vegas,” films, for example, “Casino” and TVs appears from “Vega$” to “Vegas.”

Las Vegas is a big museum town in its own way. There is the Neon Museum, a stunning pile of obsolete signage, from vast casinos, for example, the Stardust and Moulin Rouge to roadside motel dice or the grinning shirt advertising a dry cleaner. At the Mob Museum, you can see Kefauver’s court, where mafiosos testified before senators, as well as the bullet-riddled brick wall from the St. Valentine’s Day Massacre. The National Atomic Testing Museum has history, science and bombs. At the Pinball Hall of Fame, you can admire and play hundreds of games. Dream of driving the 1932 Rolls-Royce Phantom II at the Auto Collections or check out Gypsy Rose Lee’s g-string at the Burlesque Hall of Fame or visit the new Polaroid Museum.

Conference Highlights

A Unique Opportunity for Advertisers and Sponsors at this International event

http://hematology.conferenceseries.com/sponsors.php

Associations in USA

  • Surburban Hematology & oncology associations
  • Platelet association of Hematology
  • Pedimont Cancer association for Hematology
  • Associations of VA Hematology & Oncology
  • Charleston association for Hematology & Oncology
  • Atlanta Cancer association for Hematology
  • Georgia Cancer association for Hematology
  • Winship Cancer association
  • Childhood Cancer association
  • Michigan society of Hematology
  • ASH Education program on Hematology
  • Hematology Oncology society of Ohio
  • International society for Experimental Hematology
  • The Division of Hematology & Oncology
  • International society for Laboratory Hematology
  • Medical college for Wisconsin Hematology & Oncology
  • The British Committee for Hematology & Oncology
  • International society for Thrombosis & Hemostasis
  • Pan-European and International Partners of Hematology
  • The Leukemia & Lymphoma Society
  • Children’s Healthcare of Atlanta
  • American Diabetes Association
  • American Society of Hematology
  • American Association of Blood Banks
  • American Cancer Society

 Associations Worldwide

  • Healio
  • United Kingdom Thalassemia Society
  • British Society for Haematology
  • Life South Community Blood Centers
  • Shepard Community Blood Center
  • Southeastern Community Blood Center
  • Centers for Disease Control and Prevention
  • World congress of the International society of Hematology
  • International society of Hematology
  • World federation of Hemophilia
  • European Hematology Associations
  • XXXV World congress of the International Society
  • 33rd International Society of Hematology
  • XXXI World congress of the International society of Hematology
  • Malaysian society of Hematology
  • Armenian associations of Hematology & Oncology
  • Japanese society of Hematology

Universities in USA

  • American Intercontinental University
  • Clark Atlanta University
  • Emory University
  • Devry University
  • Georgia institute University
  • Georgia state University
  • Interdenominational Theological University
  • John Marshall University
  • Mercer University
  • Morehouse University
  • American National  University
  • Art Institute University
  • Atlanta Metropolitan University
  • Bauder University
  • Chamberlain University
  • Herzing University
  • Morehouse University
  • Morris Brown University
  • Sarvannah University
  • The Salvation Army Evangeline Booth
  • Emory University School of Medicine
  • Morehouse School of Medicine
  • Mercer University School of Medicine
  • Georgia Regents University Medical College of Georgia
  • Harvard University
  • University of Michigan
  • Yale University
  • Stanford University
  • Maryland Marlene University
  • Stewart Greene Baum University
  • Arizona University
  • Alabama University
  • Cincinnati University
  • Thomas Jefferson University
  • Colorado University
  • Vermont University
  • Feinberg University
  • Chicago University
  • University of California & San Francisco
  • University of Southern California
  • University of IIIinois

 Universities Worldwide

  • University of Oxford
  • The University of Melbourne
  • University of Glasgow
  • Fudan University
  • Shanghai Jiao Tong University
  • European School of Hematology
  • The University of Tokyo
  • Osaka University
  • University of Bari
  • Stanford University
  • University of Minnesota
  • University of Albert
  • University of Nebraska
  • University of IOWA CARVER
  • University of Pennsylvania
  • Southwestern University
  • University of Pittsburgh
  • Northwest University of Finberg
  • University of Helsinki
  • University of Penn Medicine
  • University of Wisconsin-Madison
  • University of Irvine

Companies in USA

  • Johnson & Johnson -
  • Pfizer
  • Merck
  • Eli Lilly & Co
  • Abbott Laboratories
  • Sanofi
  • Amgen
  • Actavis
  • Bristol-Myers Squibb
  • Biogen Idec
  • Abbvie
  • Advaxis
  • Alcon
  • Anavex life science
  • Avax Technologies
  • Amico Laboratories
  • Boehringer-Ingelheim
  • Hovione
  •  Companies inWorldwide:
  • Horiba
  • SFRI
  • Dymind biotech
  • Accubiotech ltd
  • Perlong medical
  • Ratyo
  • Prokan
  • Heska
  • Mindray
  • Abbott diagnostic
  • IDEXX laboratories
  • Nihon Khonden
  • ERBA
  • BECKMAN diagnostic
  • SIEMENS
  • Human diagnostics
  • QBC Diagnostics
  • Diatron groups
  • Boule
  • URIT

Hospitals in USA

  • Childerns health care
  • Gardy memorial 
  • Atlanta medical center
  • Emory hospital
  • Select specality
  • Kindered 
  • Atlanta central mediacl research
  • Hillside 
  • Laurel medical
  • Piedmont Atlanta hospital
  • Shepherd
  • South Fulton mediacl
  • Welsely woods geriatic
  • Deklab medical
  • Anchor
  • Ridgeview
  • Northside hospital
  • Presbyterian Hospital
  • Johns Hopikan
  • Dana-Farber
  • Brigham
  • Stanford
  • Massachusetts
  • Keck
  • Barnes-Jewish
  • Jefferson's
  • Mayo Clinic
  • Chicago
  • Vijaya group
  • Sheba medical
  • Cleveland clinic
  • Icahn

Hospitals in Worldwide

  • Leiden University Medical Center
  • Royal Cancer Hospital
  • King’s College Hospital
  • Clatterbridge Center for Oncology
  • Northampton General Hospital
  • Cambridge University Hospitals
  • University Hospital Southhampton
  • Central Manchester University Hospitals
  • Southend University Hospital
  • Kingston Hospitals
  • Bradford Hospital
  • Institute of Oncology, Ljubljana
  • Institut Gustave Roussy, Paris
  • Paterson Institute On Cancer Research,UK
  • Christie Hospitals
  • Wellington Hospital
  • Imperial College Hospital
  • Curie Institute
  • The Royal Marsden Hospital in London, England

Glance at Market of Hematology

According to market study, market value of Hematology at present is $15.13 billion. A major part of research is going on at the top Universities across the globe, the grants allotted for this research field is around $10.54 billion. Many companies are associated with the blood testing equipment along with various diagnostic instruments, hematologic drugs and other therapeutics, the revenue generated is around $21.1 billion on average by this companies. Besides this various societies and research labs are also associated in this research field. More than 40% research work on Hematology is going on in USA, as around 176 Universities in USA are working in this field, along with 24 Societies, besides that  there are almost 40 companies in USA which deals with diagnostic and testing equipment. Market value of Hematology at present in USA is $3.13 billion at present, university grants allotted by government is about $2.10 billion and average revenue generated by the industries in USA is $8.1billion. The global hematology market is divided into hematology products& hematology services. The hematology products segment holds the largest share of the hematology market in 2017. It is also expected to grow at the highest growth rate by next five years, owing to the increasing development of new hematology reagents. In addition, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs. The clinical testing labs hold the largest share of the hematology market in 2017.

Past Conference Report

Hematology 2016
 

Hematology 2016 : Past Conference Report

The success of the Hematology 2016 conference has given us the prospect to bring the gathering one more time. Conferenceseries LLC hosted the “6th International Conference on Hematology” during October 03-05, 2016 at Double Tree by Hilton Hotel, Orlando Airport, USA,

The conference was focused on Blood Disorder Research studies with the theme “Integrating Hematology Research Under A Single Roof”. The meeting engrossed a vicinity of comprehensive discussions on novel subjects like Hematologic Oncology, Immunology, Blood Transplantation, Blood Disorders, Diagnosis In Blood Disorder, Hematology Research, Hematology, Various Aspects of Hematology and so on.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

 

  • Knox Van dyke, West Virginia University, USA
  • C Cameron Yin, The University of Texas MD Anderson Cancer Center, USA
  • Robert Michael Davidson, American Institute of Stress, USA
  • Dianzheng Zhang, Philadelphia College of Osteopathic Medicine, USA
  • Enzi Jiang, University of Southern California, USA

Best Poster Awardee: Khulud Abudawood, University of Florida College of Nursing, USA

Conferenceseries LLC offers its heartfelt appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries LLC and supported the conference in every aspect, without which the conference would not have been possible.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Hematology  2017, Conferenceseries LLC would like to announce the commencement of the “11th International Conference on Hematology and Hematological Oncology” to be held during November 08-09, 2017 in Las Vegas, Nevada, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Hematology Research.

 

For More details: http://hematology.conferenceseries.com/

 

                                                        Let us meet again @ Hematology 2017

 

To Collaborate Scientific Professionals around the World

Conference Date November 08-09, 2017

Speaker Opportunity

Supported By

Journal of Blood Disorders & Transfusion Journal of Blood & Lymph Journal of Hematology & Thromboembolic Diseases

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by